🕵️ Parabilis Medicines, Inc. ($PBLS)
SEC insider & ownership activity, last 12 months · CIK 1657677 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.
Insider flow
3 buyers, value withheld pending verification (14 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 8 | value withheld pending verification | 0 | – | Jul 22, 2026 |
| Sebulsky Alan | 4 | value withheld pending verification | 0 | – | Jun 15, 2026 |
| Levy Guy | 2 | value withheld pending verification | 0 | – | Jun 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 23.8% | 13D | Jun 11, 2026 | filing ↗ | |
| Peter Kolchinsky | 23.8% | 13D | Jun 11, 2026 | filing ↗ | |
| Rajeev Shah | 23.8% | 13D | Jun 11, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 21.6% | 13D | Jun 11, 2026 | filing ↗ | |
| FMR LLC | 8.5% | 13G | Aug 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 8.5% | 13G | Aug 6, 2026 | filing ↗ | |
| ARCH Venture Fund XII, L.P. | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| ARCH Venture Partners XII, L.P. | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| ARCH Venture Partners XII, LLC | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Robert Nelsen | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Keith Crandell | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Kristina Burow | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Steven Gillis | 5.3% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 22, 2026 | filing ↗ |
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 9, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |